• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Polyp Biopsy Market Analysis

    ID: MRFR/MED/1141-HCR
    90 Pages
    Kinjoll Dey
    October 2025

    Polyp Biopsy Market Research Report Information by Type (Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy and Laryngoscopy), Distribution Channel (Online Sales Channels, Retail Pharmacies), End User (Hospitals & Clinics, Diagnostic Centres and Academic & Research Organizations) - Forecast till 2035.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Polyp Biopsy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Polyp Biopsy Market Industry Landscape

    The PolyP biopsy market develops innovative methods to detect and assess polyps in body areas including the digestive system. PolyP testing are crucial for early detection and prevention of polyp-related malignancies. Rising colon polyps affect the market. Lifestyle, diet, and aging are increasing polyps. Better diagnostics like PolyP tests help physicians detect them early. Endoscopic instruments improve, changing the market. Many endoscopic procedures involve polyP biopsies. High-definition imaging, magnification, and improved endoscopic equipment enable surgeons spot polyps. The market values early polyp detection and prevention. This approach relies on polyP biopsies to detect and remove precancerous polyps before they become colon cancer. The technology of biopsy equipment is continually improving. PolyP biopsy instruments including tweezers, snares, and brushes are more accurate, simpler to use, and better at collecting tissue samples for diagnosis. Adding CT and MRI to PolyP biopsies is transforming the market. Fusion biopsies improve targeting and sample accuracy by combining imaging data with real-time biopsy operations. Customized medication and targeted therapies are transforming markets. PolyP biopsies help physicians modify medications to decrease adverse effects and improve efficacy. Following strong quality assurance standards and guidelines is crucial to market shaping. PolyP biopsy equipment must fulfill regulator-mandated safety, efficacy, and reliability requirements to provide accurate diagnosis. Patient education campaigns are crucial to the market. Regular PolyP biopsies and education about their importance lead to earlier diagnosis, improved patient participation, and better outcomes. AI in PolyP biopsy research is a notable trend. When AI systems analyze tumor samples, they assist clinicians uncover tiny issues and improve diagnostic accuracy. Economic issues like healthcare expenditure and payment regulations impact market dynamics. The affordability and accessibility of PolyP biopsy procedures are crucial to their widespread usage and equitable access to early diagnostic services. Global PolyP biopsy market growth is impacted by efforts to make the operation simpler. Healthcare organizations, manufactures, and regulators may expand PolyP biopsy therapies to improve colon health worldwide by cooperating together. Patient satisfaction and less invasive procedures shift the market. PolyP biopsies should reduce discomfort and make patients more comfortable, encouraging screening and compliance. Environmental concerns with PolyP biopsy procedures are growing in the market. Sustainable approaches like reducing garbage and maximizing resources integrate with the eco-friendly healthcare trend.

    Market Summary

    The Global Polyp Biopsy Market is projected to grow from 1.58 USD Billion in 2024 to 3.56 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Polyp Biopsy Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 7.68% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 3.56 USD Billion, indicating substantial growth potential. In 2024, the market is valued at 1.58 USD Billion, laying a solid foundation for future expansion. Growing adoption of advanced biopsy technologies due to increasing awareness of colorectal cancer screening is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.58 (USD Billion)
    2035 Market Size 3.56 (USD Billion)
    CAGR (2025-2035) 7.68%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Cardinal Health, Inc., Angiotech, Carefusion Corporation, R. Bard, Inc., Hologic, Inc., INRAD Inc., NeoDynamics AB, Devicor Medical Products Inc., Olympus, IZI Medical Products, DTR Medica</p>

    Market Trends

    <p>The increasing prevalence of colorectal cancer and the growing awareness of early detection strategies are driving advancements in polyp biopsy techniques, which may enhance diagnostic accuracy and patient outcomes.</p>

    U.S. National Cancer Institute

    Polyp Biopsy Market Market Drivers

    Market Growth Projections

    The Global Polyp Biopsy Market Industry is poised for substantial growth, with projections indicating a market value of 1.58 USD Billion in 2024 and an anticipated increase to 3.56 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 7.68% from 2025 to 2035, highlighting the increasing demand for polyp biopsy procedures driven by various factors such as rising colorectal cancer incidence, advancements in biopsy techniques, and government initiatives promoting screening.

    Growing Geriatric Population

    The aging population worldwide is a crucial factor propelling the Global Polyp Biopsy Market Industry. Older adults are at a higher risk for developing colorectal polyps and cancer, leading to an increased need for screening and biopsy procedures. As the global demographic shifts towards an older population, healthcare systems are likely to see a surge in demand for polyp biopsies. This trend is expected to be reflected in market growth, with projections indicating a rise to 3.56 USD Billion by 2035. The correlation between age and cancer incidence underscores the importance of addressing this demographic shift in the context of market expansion.

    Advancements in Biopsy Techniques

    Technological innovations in biopsy techniques are significantly influencing the Global Polyp Biopsy Market Industry. Enhanced imaging technologies, such as high-definition endoscopy and virtual colonoscopy, improve the accuracy of polyp detection and characterization. These advancements not only facilitate earlier diagnosis but also increase the efficiency of biopsy procedures. As healthcare providers adopt these cutting-edge technologies, the demand for polyp biopsies is likely to surge. This shift towards more sophisticated diagnostic methods aligns with the industry's growth trajectory, as evidenced by the anticipated market expansion to 3.56 USD Billion by 2035.

    Increased Awareness and Education

    Heightened awareness and education regarding colorectal health are driving factors in the Global Polyp Biopsy Market Industry. Campaigns aimed at educating the public about the risks of colorectal cancer and the importance of early detection have led to increased screening rates. As individuals become more informed about the benefits of polyp biopsies, they are more likely to seek these procedures. This growing awareness is anticipated to contribute to the market's expansion, with estimates suggesting a market value of 1.58 USD Billion in 2024, potentially reaching 3.56 USD Billion by 2035.

    Rising Incidence of Colorectal Cancer

    The increasing prevalence of colorectal cancer globally is a primary driver for the Global Polyp Biopsy Market Industry. As awareness of the disease rises, more individuals undergo screening procedures, leading to a higher demand for polyp biopsies. According to health statistics, colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. This trend is expected to contribute to the market's growth, with projections indicating that the market will reach 1.58 USD Billion in 2024 and potentially expand to 3.56 USD Billion by 2035, reflecting a compound annual growth rate of 7.68% from 2025 to 2035.

    Government Initiatives and Screening Programs

    Government initiatives aimed at promoting cancer screening are pivotal in shaping the Global Polyp Biopsy Market Industry. Many countries have implemented national screening programs that encourage early detection of colorectal cancer. These programs often include recommendations for regular colonoscopies, which inherently involve polyp biopsies. As a result, the number of individuals undergoing these procedures is expected to rise, thereby driving market growth. The proactive stance taken by health authorities not only raises awareness but also enhances accessibility to screening services, contributing to the projected market value of 1.58 USD Billion in 2024.

    Market Segment Insights

    Regional Insights

    Key Companies in the Polyp Biopsy Market market include

    Industry Developments

    IZI Medical Products, LLC, a major developer of medical devices used in interventional radiology and interventional oncology treatments, has launched the Quick-Core Auto Biopsy Systems for polyp biopsy. The Quick-Core Auto is a portable, fully automatic biopsy devices that enhances the dependability, precision, and quality of IZI's semi-automatic Quick-Core biopsy system.

    NeoDynamics AB, a MedTech company focused to improve breast cancer diagnosis and treatment, has announced a collaboration with the Buckinghamshire Healthcare NHS Trust in London for their NeoNavia pulse biopsy device.

     

    Future Outlook

    Polyp Biopsy Market Future Outlook

    <p>The Polyp Biopsy Market is poised for growth at 7.68% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of colorectal cancer, and rising awareness of preventive healthcare.</p>

    New opportunities lie in:

    • <p>Develop innovative biopsy devices integrating AI for enhanced diagnostic accuracy. Expand telehealth services for remote consultations and follow-ups in polyp management. Invest in educational programs to raise awareness about the importance of regular screenings.</p>

    <p>By 2035, the Polyp Biopsy Market is expected to achieve substantial growth, reflecting advancements and increased healthcare engagement.</p>

    Market Segmentation

    Report Scope

    Attribute/MetricDetails
    Market Size 2022N/A (USD Billion)
    Market Size 2023N/A (USD Billion)
    Market Size 20322.8 (USD Billion)
    Compound Annual Growth Rate (CAGR)8.3 % (2024- 2032)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2022
    Market Forecast Period2023 - 2032
    Historical Data2019 - 2022
      Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors  Cardinal Health, Inc., Angiotech, Carefusion Corporation, C.R. Bard, Inc., Hologic, Inc., INRAD Inc., Devicor Medical Products Inc., Olympus, and DTR Medica
      Key Market Opportunities  Growing geriatric populations, and increasing prevalence of colorectal cancer are projected to drive the market growth.
      Key Market Drivers  On the other hand, uncertain regulatory issues and biopsy-related risk of infections are expected to restrict the market growth during the forecast period.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What would be the polyp biopsy market CAGR during the forecast period of 2022 to 2030?

    Polyp biopsy market CAGR would be 8.3% during the forecast period.

    Who are the players involved in the polyp biopsy market report?

    The players in polyp biopsy report areAngiotech, INRAD Inc., Cardinal Health, Inc., Hologic, Inc., Carefusion Corporation, C.R. Bard, Inc., Olympus, Devicor Medical Products Inc., and DTR Medica.

    Name the region to lead the polyp biopsy market.

    The Americas would lead the polyp biopsy market.

    Mention the polyp biopsy market valuation by 2030.

    Polyp biopsy market valuation would be USD 2.8 Billion.

    Name the distribution channels included in the polyp biopsy market report.

    The distribution channels of polyp biopsy market report are online sales channel and retail pharmacies.

    1. Definition
      1. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
      2. Overview
      3. Primary Research
      4. Secondary Research
      5. Market Size Estimation
      6. Drivers
      7. Restraints
      8. Opportunities
      9. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      10. Value Chain Analysis
        1. R&D and Designing
        2. Manufacturing
        3. Distribution & Sales
        4. Post-Sales Review
    2. Chapter 6. Global Polyp Biopsy Market, by Type
      1. \r\n
      2. Overview
      3. \r\n
      4. Colonoscopy
      5. \r\n
    3. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    4. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Colposcopy-Directed Biopsy
      3. \r\n
    5. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    6. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Esophagogastroduodenoscopy
      3. \r\n
    7. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    8. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Laryngoscopy
      3. \r\n
    9. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    10. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. \r\n
      3. \r\n
    11. Chapter 7. Global Polyp Biopsy Market, by Distribution Channel
      1. \r\n
      2. Overview
      3. \r\n
      4. Online Sales Channels
      5. \r\n
    12. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    13. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Retail Pharmacies
      3. \r\n
    14. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    15. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
    16. Chapter 8. Global Polyp Biopsy Market, by End User
      1. \r\n
      2. Overview
      3. \r\n
      4. Hospitals & Clinics
      5. \r\n
    17. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    18. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Diagnostic Centers
      3. \r\n
    19. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    20. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. Academic & Research Organizations
      3. \r\n
    21. Market Estimates & Forecast, by Region, 2020-2027
      1. \r\n
    22. Market Estimates & Forecast, by Country, 2020-2027
      1. \r\n
      2. \r\n
    23. Chapter 10. Global Polyp Biopsy Market, by Region
      1. \r\n
      2. Overview
      3. \r\n
      4. Americas
        1. North America
        2. Latin America
      5. \r\n
      6. \r\n
      7. \r\n
      8. \r\n
      9. \r\n
      10. Europe
        1. Western Europe
        2. Eastern Europe
      11. \r\n
      12. \r\n
      13. \r\n
      14. \r\n
      15. \r\n
      16. \r\n
      17. \r\n
      18. \r\n
      19. \r\n
      20. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      21. \r\n
      22. \r\n
      23. \r\n
      24. \r\n
      25. \r\n
      26. \r\n
      27. \r\n
      28. Middle East & Africa
        1. Middle East
        2. Africa
      29. \r\n
      30. \r\n
      31. \r\n
      32. Chapter 11. Company Landscape
      33. \r\n
      34. Overview
      35. \r\n
      36. Competitive Analysis
      37. \r\n
      38. Chapter 12. Company Profile
      39. \r\n
      40. Angiotech
        1. Company Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      41. \r\n
      42. \r\n
      43. \r\n
      44. \r\n
      45. \r\n
      46. \r\n
      47. \r\n
      48. Cardinal Health, Inc.
        1. Company Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      49. \r\n
      50. \r\n
      51. \r\n
      52. \r\n
      53. \r\n
      54. \r\n
      55. \r\n
      56. Carefusion Corporation
        1. Company Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
        6. Key Strategies
      57. \r\n
      58. \r\n
      59. \r\n
      60. \r\n
      61. \r\n
      62. \r\n
      63. \r\n
      64. C.R. Bard, Inc.
        1. Company Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
        6. Key Strategies
      65. \r\n
      66. \r\n
      67. \r\n
      68. \r\n
      69. \r\n
      70. \r\n
      71. \r\n
      72. Devicor Medical Products Inc.
        1. Company Overview
        2. Products/Services Offered
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      73. \r\n
      74. \r\n
      75. \r\n
      76. \r\n
      77. \r\n
      78. \r\n
      79. \r\n
      80. DTR Medical
        1. Company Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      81. \r\n
      82. \r\n
      83. \r\n
      84. \r\n
      85. \r\n
      86. \r\n
      87. \r\n
      88. Hologic, Inc.
        1. Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      89. \r\n
      90. \r\n
      91. \r\n
      92. \r\n
      93. \r\n
      94. \r\n
      95. \r\n
      96. INRAD Inc.
        1. Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      97. \r\n
      98. \r\n
      99. \r\n
      100. \r\n
      101. \r\n
      102. \r\n
      103. \r\n
      104. Olympus
        1. Overview
        2. Products/Services Offered
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      105. \r\n
      106. \r\n
      107. \r\n
      108. \r\n
      109. \r\n
      110. \r\n
      111. \r\n
      112. Others
      113. \r\n
      114. Chapter 13 Appendix
      115. \r\n
      116. References
      117. \r\n
      118. Related Reports
      119. \r\n
      120. \r\n
    24. LIST OF TABLES
      1. \r\n
    25. Global Polyp Biopsy Market Synopsis, 2020-2027
      1. \r\n
    26. Global Polyp Biopsy Market Estimates and Forecast, 2020-2027 (USD Million)
      1. \r\n
    27. Global Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    28. Global Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    29. Global Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    30. Global Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
      1. \r\n
    31. Americas: Polyp Biopsy Market, by Region, 2020 and 2025
      1. \r\n
    32. Americas: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    33. Americas: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    34. Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    35. North America: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
      1. \r\n
    36. North America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    37. North America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    38. North Americas Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    39. US: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    40. US: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    41. US: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    42. Canada: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    43. Canada: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    44. Canada: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    45. Latin America: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    46. Latin America: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    47. Latin America: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    48. Europe: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
      1. \r\n
    49. Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    50. Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    51. Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    52. Western Europe: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
      1. \r\n
    53. Western Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    54. Western Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    55. Western Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    56. Eastern Europe: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    57. Eastern Europe: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    58. Eastern Europe: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    59. Asia-Pacific: Polyp Biopsy Market, by Country, 2020-2027 (USD Million)
      1. \r\n
    60. Asia-Pacific: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    61. Asia-Pacific: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    62. Asia-Pacific: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
    63. Middle East & Africa: Polyp Biopsy Market, by Region, 2020-2027 (USD Million)
      1. \r\n
    64. Middle East & Africa: Polyp Biopsy Market, by Type, 2020-2027 (USD Million)
      1. \r\n
    65. Middle East & Africa: Polyp Biopsy Market, by Distribution Channel, 2020-2027 (USD Million)
      1. \r\n
    66. Middle East & Africa: Polyp Biopsy Market, by End User, 2020-2027 (USD Million)
      1. \r\n
      2. \r\n
    67. LIST OF FIGURES
      1. \r\n
    68. Research Process
      1. \r\n
    69. Market Structure for Global Polyp Biopsy Market
      1. \r\n
    70. Market Dynamics for Global Polyp Biopsy Market
      1. \r\n
    71. Global Polyp Biopsy Market Share, by Type, 2020 (%)
      1. \r\n
    72. Global Polyp Biopsy Market Share, by Type, 2020 (USD Million)
      1. \r\n
    73. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (%)
      1. \r\n
    74. Global Polyp Biopsy Market Share, by Distribution Channel, 2020 (USD Million)
      1. \r\n
    75. Global Polyp Biopsy Market Share, by End User, 2020 (%)
      1. \r\n
    76. Global Polyp Biopsy Market Share, by End User, 2020 (USD Million)
      1. \r\n
    77. Global Polyp Biopsy Market Share, by Region, 2020 (%)
      1. \r\n
    78. Americas: Polyp Biopsy Market Share, by Region, 2020 (%)
      1. \r\n
    79. North America: Polyp Biopsy Market Share, by Country, 2020 (%)
      1. \r\n
    80. Europe: Polyp Biopsy Market Share, by Region, 2020 (%)
      1. \r\n
    81. Asia-Pacific: Polyp Biopsy Market Share, by Country, 2020 (%)
      1. \r\n
    82. Middle East & Africa: Polyp Biopsy Market Share, by Region, 2020 (%)
      1. \r\n
    83. Global Polyp Biopsy Market: Company Share Analysis, 2020 (%)
      1. \r\n
    84. Angiotech: Key Financials
      1. \r\n
    85. Angiotech: Segmental Revenue
      1. \r\n
    86. Angiotech: Regional Revenue
      1. \r\n
    87. Cardinal Health, Inc.: Key Financials
      1. \r\n
    88. Cardinal Health, Inc.: Segmental Revenue
      1. \r\n
    89. Cardinal Health, Inc.: Regional Revenue
      1. \r\n
    90. Carefusion Corporation: Key Financials
      1. \r\n
    91. Carefusion Corporation: Segmental Revenue
      1. \r\n
    92. Carefusion Corporation: Regional Revenue
      1. \r\n
    93. C.R. Bard, Inc.: Key Financials
      1. \r\n
    94. C.R. Bard, Inc.: Segmental Revenue
      1. \r\n
    95. C.R. Bard, Inc.: Regional Revenue
      1. \r\n
    96. Devicor Medical Products Inc.: Key Financials
      1. \r\n
    97. Devicor Medical Products Inc.: Segmental Revenue
      1. \r\n
    98. Devicor Medical Products Inc.: Regional Revenue
      1. \r\n
    99. DTR Medical: Key Financials
      1. \r\n
    100. DTR Medical: Segmental Revenue
      1. \r\n
    101. DTR Medical: Regional Revenue
      1. \r\n
    102. Hologic, Inc.: Key Financials
      1. \r\n
    103. Hologic, Inc.: Segmental Revenue
      1. \r\n
    104. Hologic, Inc.: Regional Revenue
      1. \r\n
    105. INRAD Inc.: Key Financials
      1. \r\n
    106. INRAD Inc.: Segmental Revenue
      1. \r\n
    107. INRAD Inc.: Regional Revenue
      1. \r\n
    108. Olympus: Key Financials
      1. \r\n
    109. Olympus: Segmental Revenue
      1. \r\n
    110. Olympus: Regional Revenue

    Polyp Biopsy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials